NNovo Nordisk Read More LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials2026-06-30 Foundayo is already approved by the FDA for obesity. Lilly said it plans to submit Foundayo for U.S.…